Evaluating the response of animals to a toxic or therapeutic agent requires the knowledge of the dose of the agent in the respiratory tract. Dose is the amount retained in the lungs. It is the difference between the amount deposited and the amount cleared. Many factors influence the amount of and the site of deposition in the respiratory tract. For particles, the characteristics of the aerosol, most importantly size, the physiology of the animal, most importantly breathing pattern, and the geometry of the respiratory tract all play a role in determining local dose. These factors and their relative importance in determining regional deposition are discussed. Finally, ways in which dose can be measured in the respiratory tract are explored. These range from simple estimates of total dose using whole lung digests to the precise localization of dose in well-defined lung compartments using morphometry or in cellular or subcellular compartments using electron energy loss spectroscopy. The techniques utilized by an investigator depend on the amount of resolution desired. Their use and implementation in inhalation studies are the key to fully understanding the response of an animal to an inhaled toxic or therapeutic agent.
Evaluating actions of inhaled materials is a complex endeavor. To obtain dose response curves, animals are routinely exposed to increasing concentrations of toxic or therapeutic agents. Typically, investigators assume that increasing the exposure concentration will lead to a proportional increase in lung dose and consequently an increase in animal response. This is only true when the characteristics of the aerosol, the physiology of the animal, and the geometry of the respiratory tract do not change as the exposure concentration increases. These assumptions may be false. For example, increasing chamber concentrations to 5 mg/m3 can result in particle aggregation, increased particle size, and a lower respirable fraction inside the chamber. Animals exposed to these aerosols will inhale fewer particles that are larger in size which in turn will affect the site of deposition in the lungs. If the agent is irritating, the animal may alter its breathing pattern. Such agents may cause bronchoconstriction as well as more rapid and shallow breathing. These changes will enhance the central airway deposition of inhaled particles and limit the fi-action delivered to and deposited in the peripheral lung parenchyma. Finally, the particles may cause inflammation, cell damage, and/or chronic alterations in lung structure. These changes in the dimensions of airways and airspaces will alter the distribution of inspired gas and thus affect the amount and distribution of particles deposited in the respiratory tract.
Many investigators measure only the histologic, physiologic, or biochemical response of the exposed animals. To evaluate response, accurate estimates of the dose of the agent at the site of lung injury must be measured. Moreover, quantification of dose is essential for comparison of results among different investigators and laboratories. Similar experiments cannot be compared unless the dose, and preferably the distribution of dose, can be described. Dose is the amount of particles retained in the lung at any time following exposure (depositionclearance). The dose as well as the inherent toxicity of the particle determines the risk for subsequent pulmonary damage. In this review, we discuss some of the factors that are important determinants of regional lung dose of inhaled particles and gases. Our efforts will
